Thermo Fisher Makes Final Push For ‘Universal’ Lung-Cancer Companion Dx

The Oncomine Universal Dx looks in parallel for mutations on four genes associated with non-small cell lung cancer to help physicians pick between different drug options. Thermo Fisher has submitted its final PMA module to FDA.